InvestorsHub Logo
icon url

bb8675309

12/22/20 9:02 PM

#289555 RE: tredenwater2 #289549

Right. You have a cutting edge company in technology that has the best safety record ( Over Five years) in a drug that has proven meeting primary and secondary end points in a drug trials in a highly unmet needed area of CNS disease. Many people are dying do to this disease and other CNS diseases.

And what do we wait for? Someone behind a curtain in a 30 year old approval culture to approve this drug. No. I don't think so.
icon url

tradeherpete

12/22/20 9:33 PM

#289558 RE: tredenwater2 #289549

This was my toned down rational question for the board.

The first 2 drafts were not as kind.

So, I agree.